Latest / The Cancer Secrets Podcast / CSP S7EO95 - Ep.95, Advancing Cancer Screening: A Conversation with Dr. Tarek Mouhieddine of POM Health
Transcript
- 0:07Hi and welcome to the Cancer Secrets podcast. I am your Host and guide,
- 0:10Dr. Jonathan Stegall. Cancer is like a thief who
- 0:14has come to steal, kill and destroy. I have personally seen
- 0:18it wreak its havoc on patients, friends, and even my own family.
- 0:22But I am on a mission to change the cancer paradigm through the practice of
- 0:26integrative oncology cancer treatment that integrates the best of
- 0:29conventional medicine with the best of alternative therapies. Backed
- 0:33by science and personalized to each patient. You
- 0:37need a positive voice you can trust. This podcast will share valuable
- 0:40information to give you practical hope for a better outcome.
- 0:44So I invite you to join me on this journey as we seek to change
- 0:47the cancer paradigm together. Well, hello
- 0:51and welcome back to the Cancer Secrets podcast. I'm your host, Dr. Jonathan Stegall,
- 0:55and this is season seven and episode number 95. And today
- 0:59we have a very special guest. Joining us is Dr.
- 1:02Tarek Mouhieddine. How are you, doctor? I'm doing great and
- 1:06thank you so much for having me today. I really appreciate it and very excited
- 1:10to talk together about what we're doing. Yeah,
- 1:14excited to have you. I'd love to introduce you to our listeners. But just so
- 1:17everyone knows, Dr. Mouhieddine is a medical doctor. He's a physician
- 1:21scientist. He's a clinical investigator whose research focuses on improving
- 1:24cancer treatment outcomes. He has a strong background in lab
- 1:28based and translational research with expertise in tumor genomics
- 1:32and the immune microenvironment. Dr. Mouhieddine is
- 1:35passionate about advancing precision cancer care in early detection and
- 1:38interpretation of blood cancers and translating laboratory
- 1:42discoveries into first in human phase 1 clinical
- 1:45trials in multiple myeloma. He completed medical school at the
- 1:49American University of Beirut and completed his internal medicine residency and
- 1:53hematology oncology fellowship at at the Icahn School of Medicine at Mount
- 1:56Sinai Hospital. He is currently on faculty at the Dana Farber Cancer
- 2:00Institute in Boston. He is also the co founder for Palm Health,
- 2:04an oncologist led cancer screening service that gives people
- 2:07access to more comprehensive cancer screening tests.
- 2:11Doctor, welcome again. Thank you. Thank you so much for having me. So I'm
- 2:14really excited to have you here today, not only because you're an oncologist who
- 2:18works in the field, but also someone who's passionate about cancer
- 2:22prevention. So if we could start out, I would just love to know more about
- 2:25what drew you to oncology as a career choice. Yeah,
- 2:28honestly, I think I would say it started when I was a
- 2:32kid, honestly. And it wasn't specifically oncology, at
- 2:36least when I was a child, but it was science I was a very
- 2:40nerdy kid at school. I loved science
- 2:44a lot. I was the one who would always stay back
- 2:47in class and just want to talk more and more with a teacher about things
- 2:50and, like, always wanted to do more experiments. So
- 2:54part of that was looking more into oncology and
- 2:58cancer. And, you know, of course, all the fields in medicine are driven
- 3:02by research, but I would say oncology
- 3:05is one of the fields that are extremely driven
- 3:09by research. And as an oncologist, honestly, even if
- 3:13you're working full time clinical, you have to have a little bit of
- 3:17some research or scientific background, because a lot
- 3:21of the things that we do has or needs at least some
- 3:24scientific or background to fully understand what's going on.
- 3:28And I would say, as I grew up, basically, I started
- 3:32being drawn slowly into the medical field in terms of interest. And
- 3:36I felt that in oncology I could
- 3:40see patients, treat them, help them, but at the same time, I could still keep
- 3:43that research passion going and be able to do two things from that
- 3:47aspect. And out of all the fields in medicine, I would say
- 3:51oncology also interested me the most compared to, let's
- 3:54say, cardiology or gi, because I
- 3:58felt that in oncology you can help a
- 4:02lot of people and really change their lives significantly.
- 4:05And it's usually, or in a lot of cases, at
- 4:09least a matter of life and death. And you can
- 4:13basically take someone from end of life to actually having
- 4:16decades again and living their life to the fullest and
- 4:21seeing their kids grow up, seeing their grandkids, and
- 4:24being part of that journey actually is very, very rewarding
- 4:28and something that I enjoy doing every day. I love that. And you clearly
- 4:32have a real heart for it, and that's. That's great. We need more doctors like
- 4:36you. Thank you. Thank you. So I'd like
- 4:39to talk about cancer screening in today's episode. And, you know,
- 4:43you and I have talked about the fact that most Americans believe they're being
- 4:47screened for cancer, but. But they're really not. And, you know, you
- 4:51said that the current, you know, standard of care for
- 4:54screening has a massive blind spot. So how did
- 4:58that gap form? Yeah. No. So I don't know if, you
- 5:02know, but the current standard of cancer screening
- 5:06or the recommendations that we have these days are actually
- 5:09decades old. They're not updated.
- 5:13Except until recently, just the colon cancer
- 5:16screening guidelines got upgraded. Exactly. But
- 5:20otherwise, when it comes to breast cancer, lung cancer, cervical
- 5:24cancer, and prostate cancer, at least
- 5:27those have been the same for so long, specifically breast
- 5:31cancer. And so the reasoning behind it, I guess I would Say
- 5:35it's. First of all, it's because they're very common cancers, so
- 5:38very easy to see all the time. And of course,
- 5:42it was much easier at least decades ago to
- 5:46screen for them and intercept and do large clinical trials
- 5:49to actually prove that screening for those cancers improves
- 5:53outcomes. When we go to other cancers which are less common, it
- 5:57becomes definitely much harder to actually run those big
- 6:00trials and prove that screening ahead of time actually
- 6:04improves outcomes. And then again, the technologies
- 6:09or the ways to screen were definitely different
- 6:12before compared to now. So now we're getting better and better at screening,
- 6:16and we're even becoming less invasive when it comes to screening.
- 6:20And I guess now that the world is changing and we
- 6:24have better tools and instruments to do that, I think
- 6:28now is the best time to start thinking about those other cancers that
- 6:31didn't really get the attention they needed. Because, you know,
- 6:35okay, breast cancer and lung cancer are top common cancers. But
- 6:39then that doesn't mean gastric cancer and bladder
- 6:42cancer are less important. There are tens of thousands of people in the US
- 6:46Alone with these cancers. And of course, they deserve to be
- 6:49screened as well for those cancers, just as well as people who
- 6:53are being screened for breast and colon. And so I think the
- 6:57intent to screen and help people, of course, is there. The problem is
- 7:01that we didn't have the tools before and we didn't have the resources.
- 7:05And usually it's a matter of balance between how many
- 7:08people out there actually will have that cancer, how much
- 7:12can the healthcare system actually do in terms of providing and
- 7:16spending, in terms of screening. And all of these things come into play.
- 7:20Unfortunately, sometimes, or the way the system works is
- 7:24there are some compromises that are made because the health
- 7:28care system in general is not able to accommodate everybody.
- 7:31Right, right. Well said. So let's talk about sort of the
- 7:35standard of care for cancer screening, if you will. We kind of touched
- 7:39on them, but we have colonoscopies for colon cancer. We have mammograms for
- 7:43breast cancer. We have, you know, Pap smears for cervical cancer, you know,
- 7:46rectal exam and PSA for prostate cancer. You got to talk a little
- 7:50bit about those. And sort of. Sort of maybe what? How.
- 7:54Just let's just assume people aren't familiar with maybe with screening. Let's.
- 7:58Let's have a. Take a. Listen. Who hasn't really thought much about screening? What does
- 8:01that look like? And then what are some of the limitations you would say are
- 8:03with each of those methods? Yeah, no, of course. So,
- 8:07you know, at least for colorectal cancer, as
- 8:11well as breast cancer, we have, as people
- 8:15know, colonoscopies and mammograms, But I would say at least
- 8:18colonoscopies, even more. They're also invasive. So
- 8:22first of all, you have the limitation of when you can do this. So the
- 8:26recommendation for colonoscopies used to be 50 years old, and then
- 8:29they recently brought it down to 45 years old. And that is mostly
- 8:33driven by the fact that we're seeing more and more cancers, unfortunately. And
- 8:37by bringing the age lower to 45, we're able
- 8:41to catch people at much earlier stages rather than
- 8:45getting them diagnosed at stage four, which is in the incurable stage.
- 8:49So the first barrier is when you can start screening, and
- 8:53the second one is, for example, colonoscopies.
- 8:56You would need to go. You would need to get anesthesia, basically,
- 9:00you will have. You will need a tube going into the colon
- 9:04and with that. Exactly. And do the prep, which is
- 9:08the most annoying part for people. And, you know, first of all,
- 9:11actually, the amount or the number of slots that are available to
- 9:15do that, that's actually a big limitation. So how many times can you do
- 9:19colonoscopies per day? And how many clinics actually
- 9:23are available to accommodate all those people? So if you just try
- 9:27and get a. So let's say you're eligible, just trying to get an
- 9:30appointment for colonoscopies. Just see how long the wait is.
- 9:34Usually it could be, depending where you are in the country, of course, it could
- 9:38be weeks to months before you can get a slot. And then even with
- 9:41that, of course, being under and going through the colonoscopy itself has
- 9:45risks. So there's risks with anesthesia, there's risks with the actual
- 9:49procedure, like causing bleeding, causing perforation in the bowel.
- 9:52So it's not safe, like 100% safe.
- 9:56There's always risks that could happen. And of course, when it
- 10:00comes to, let's say, breast cancer with mammograms,
- 10:03it's definitely not as invasive. But it also comes with
- 10:07some downsides. So, for example. So, of course, when I talk to
- 10:11patients that I have who've underwent mammograms, I
- 10:14rarely have patient who tells me it was pain free.
- 10:18They always tell me, oh, it's so painful when they have to go
- 10:22through the mammogram because it has so much pressure on compression
- 10:25tissue. Exactly. So it's an uncomfortable experience. It's not a
- 10:29dangerous experience, but it's still uncomfortable. And then you also have the fact
- 10:33that it's radiation exposure. You also have that.
- 10:37And on top of that similar to colonoscopies, you also have the age
- 10:40limit or when you can start using that and being
- 10:44covered, basically. So it's usually age 40 if you
- 10:48don't have any risk factors or like the BRCA gene or family.
- 10:51Strong family history. And so the problem is that even with
- 10:55those ages being the starting ages, I still,
- 10:59or I'm sure you have to seen patients who are in
- 11:03their 20s and 30s who come in with breast cancer and colon
- 11:06cancer specifically these days, and they're sometimes at very
- 11:10advanced stages. So the current screening
- 11:13methods are good. They can definitely detect. They are
- 11:18saving people and saving lives and helping people discover things early.
- 11:21But they're not perfect, they're not fully safe, and they're
- 11:25not fully convenient. Going into pap
- 11:28smears as well, it's a similar situation. It's uncomfortable, it's a little bit
- 11:32invasive, and, you know, right now, it. It does the trick. But
- 11:36at the same time, it's not similar to the other situations. You
- 11:40have to find an appointment. You have to go through this invasive, uncomfortable
- 11:43procedure. For prostate cancer, I would say it's probably the most
- 11:47convenient and easiest one when it comes to, like,
- 11:50PSA checking in the blood. And the hope is that most
- 11:54of these cancers can be screened in that manner.
- 11:58Of course, digital rectal exam is part of it. But
- 12:01if we can get to a stage where. Or a phase in life where
- 12:05everything can be screened for very easily without being too
- 12:09invasive, like a blood test, like the PSA for prostate cancer,
- 12:12that would be the most ideal situation. And that's what we're aiming for here.
- 12:16Right, Right. I love that. And I would agree. I mean, the methods we have
- 12:19aren't bad. They're just incomplete. Right. They need to be better. Exactly. They.
- 12:23Those tests themselves could be improved upon, I think. And then, not to mention all
- 12:26the cancers that they don't test for. Right. I mean, we talk about cancer
- 12:30as an umbrella term for over a hundred hundreds of different
- 12:34actual diseases that are under that cancer umbrella. That's a lot. We're not
- 12:37testing with our usual methods. Yeah, exactly. Typically
- 12:41don't get detected unless someone's having a. A chronic symptom of some
- 12:44sort. Yep, so. Exactly. And like, even
- 12:48mammograms, like, when we do them, like you said, they're great, and they
- 12:52can definitely detect things. But there are patients who have, for
- 12:55example, very dense tissues, and it actually doesn't help at all. You. You
- 12:59can't rely on a mammogram to really detect it. And actually, there
- 13:03are studies now to show that if you go back in time and look at
- 13:06all the mammograms that were supposedly negative and now
- 13:10you're using actually AI to look into those images, they
- 13:14are actually able to define specific very tiny areas
- 13:17that were always missed before and they were always called normal.
- 13:21And now they're calling it, oh, there was something there that should have been
- 13:25caught. And so, you know, what we have right now is good, but
- 13:29it's not perfect like you said. And there's always room for improvement.
- 13:33Dr. Mouhieddine, you're bringing up another point in my mind that, you know,
- 13:37let's also talk about false positives, right. Of how many times do, do patients
- 13:40have a test, especially mammogram, it says, oh, this is suspicious.
- 13:44The woman has, you know, a lot of anxiety around that she has to
- 13:48go back in. Does she have to have another test? Does she have to have
- 13:51a, an invasive biopsy? It turns out to be nothing. Right.
- 13:55And that happens a lot more than we like to think about and talk about.
- 13:59So. Yeah, no, that happens very frequently, unfortunately. And
- 14:02that just goes to say that our tests, I don't want to say they're bad,
- 14:06but they're not perfect because they can call
- 14:10false positives. And even worse, I, I would
- 14:14pick having a false positive over a false negative. Right. And that's
- 14:17the more dangerous side where they would say, oh, there's nothing there, while
- 14:21there actually is an early cancer that we're not able to call yet.
- 14:25Right, exactly. So that, that sort of is a nice segue too, into
- 14:29another thought I had of just this whole idea of cancer anxiety. I
- 14:33mean, we, you know, we obviously patients who have a cancer diagnosis
- 14:36have a certain degree of anxiety around, you know, what does this mean for me?
- 14:39And you know, we talk about the term scanxiety. They have to go get
- 14:43another scan. Is it going to be normal? Is it going to be abnormal? But
- 14:46we don't talk enough, in my opinion, about, about the cancer anxiety
- 14:50sort of epidemic in non cancer patients. Right. I mean, we all
- 14:54know someone who's, who's had cancer or gone through cancer and you
- 14:58know, that naturally creates a certain level of anxiety within
- 15:02us. Well, what about me? Do I have cancer? Do I need to worry about?
- 15:07So can you talk a little about what sort of peace of mind looks like
- 15:10around that and how we can do better on that? Yeah,
- 15:14no, of course. And honestly, and I think you probably
- 15:17also went through that, at least I remember throughout medical school,
- 15:22every time I learned about new things, I would
- 15:25leave the session saying, oh, I definitely have that disease. Because
- 15:29when you know more and see more around you, you just start
- 15:33trying to connect the dots, like you have a few symptoms and you say, oh,
- 15:36what if I have this? Or what if I have that? Absolutely right. And so
- 15:40I think because of that I feel, and I mean, back then
- 15:44I was a medical student and, you know, I didn't know as much and I
- 15:47was still in the learning process. And I feel the reason why I'm
- 15:51not like that anymore is because I have more knowledge and
- 15:54I have better expectations about things and
- 15:58like, experience made things better. And this is how
- 16:02Palm Health can help. And you know, as a patient who
- 16:06usually, or a person who's not sick, fully healthy, and
- 16:09maybe doesn't have a medical background, they would of course see
- 16:13cancer being on the rise. For example, have a few family members or
- 16:17friends with cancer, and they start thinking to themselves, what if
- 16:21it's me? What if it was me? And, you know, not knowing
- 16:24much about the cancer risk and what to look for is
- 16:28a major driver of this concern and anxiety, I think. And
- 16:32that's why I'm bringing up myself as an example
- 16:36when I was a student versus now, where, because I
- 16:39know more and I know what to think about and what to look for my
- 16:43anxiety, or I would say I wouldn't have that. I don't have
- 16:47that anxiety anymore. And so where Palm Health helps
- 16:51and why we created this way, we wanted it to
- 16:54be oncologist led. And that basically means
- 16:58that everybody who connects with us has
- 17:02an oncologist in one way or another. And so
- 17:06the way the system works right now is that
- 17:10when you don't have a diagnosis of cancer, you cannot see an
- 17:14oncologist. Usually when you see an oncologist, you have to come in with that
- 17:17diagnosis. Right. And so people will ask
- 17:21their primary care physician who would be amazing and great at
- 17:25what they do, but they don't see cancer every day, and it's not part
- 17:29of their learning process and experience. So they
- 17:33might not have all the answers that would address people's anxieties
- 17:36compared to if you actually don't have a cancer diagnosis, but
- 17:40you have access to talk to an oncologist,
- 17:44bring up your worries, talk about why you think you might
- 17:47have cancer or what's worrying you, and then you have someone who has that
- 17:51background that actually can guide you through it and tell you if
- 17:55you really should be worried or that you're just
- 17:58a very, very, very low risk person to develop cancer.
- 18:02I think that's one of the positive things about Palm
- 18:06Health. So it's not just about testing and screening, but it's about actually having
- 18:10someone you can bring up these points to and discuss things and
- 18:14hopefully give you a peace of mind when it comes to really your
- 18:18cancer risk. And I think that is the highlight of this
- 18:21platform, even more than the actual screening itself. Because a lot
- 18:25of people that I've already spoken to right now so far
- 18:29through Palm Health actually start feeling better just through
- 18:32that visit alone and even before we test for anything.
- 18:36And I think a lot of the worry that they bring in is I
- 18:39definitely never dismiss any worry or anxiety because I understand where
- 18:43they're coming from. But at least when they bring it up, I am able to
- 18:47address it and tell them that you actually shouldn't be worried
- 18:51that much or in a few cases, I guess. Okay,
- 18:54yeah, I think, yeah, we definitely need to investigate this and do the
- 18:58next step. So I think that's a great factor that helps
- 19:02people. Well. And Palm is actually an acronym for peace of mind,
- 19:05right? Yeah, exactly. The name. Palm Health. Yeah. Yeah,
- 19:09I love that. So you're one of the co founders of Palm
- 19:13Health. I mean, just tell us, tell us a little bit more about sort of
- 19:16what led you to start this. I mean, did you just see sort of a
- 19:18lack of resources out in the marketplace for this kind of thing?
- 19:22Yeah. So honestly this, of course
- 19:26it wouldn't have been possible without the other co founders. You know,
- 19:30to me it was definitely an idea and it was also an
- 19:33idea with the other co founders with me. And I think the
- 19:37stars aligned and made us meet and actually
- 19:41discover that we all have similar idea and a similar concern about
- 19:45things. And from at least from my standpoint, the way or the
- 19:49reason why I thought about it and wanted to do something like this
- 19:52comes from when I was back in training for during my
- 19:56oncology years of training. So of course I was
- 20:00younger and I was in my 20s and you know,
- 20:04I was seeing patients from all types of cancers. So during your training
- 20:08you don't focus on one specific things, you see all types of cancers and
- 20:12crazy. I was seeing very young people, younger than
- 20:15I was. Even with cancers that
- 20:19we normally don't see until your 50s or
- 20:2360s or 70s, I was seeing those in 20
- 20:26something year olds and 30 something year olds and that drove me
- 20:30crazy. Those patients would come in to the hospital because they're
- 20:34sick for with whatever symptom they have, they don't know what's going
- 20:38on. We admit them, we start the workup and we discover, I
- 20:41can't forget several of those Patients where they were 20
- 20:45something year olds and we would find stage 4
- 20:49metastatic colon cancer. And the crazy part about that
- 20:52is that they didn't even have risk factors. They didn't
- 20:56have a strong family history of colon cancer, they didn't get exposed to
- 21:00anything that would explain this and they still got it.
- 21:03I'm not saying it's a huge portion of patients, but it
- 21:07exists. And because of that, that made me go
- 21:11back and think, okay, we are screening patients starting age.
- 21:14Usually it used to be 50 and then it went down to 45, but then
- 21:18I'm seeing patients with stage four cancer in their 30s and
- 21:2220s. Yep. Yeah, so what, what are we going to do with that?
- 21:25And, and you know, the guidelines to screen for at
- 21:2945 still allows you to screen younger if
- 21:33you have a strong family history. So sure that that
- 21:37can help, but what about the people that I saw that didn't
- 21:41have any risk factors? They would never be eligible with the current guidelines.
- 21:44And so with that in mind and me seeing how the world
- 21:48is changing in science and me having such a
- 21:51nerdy interest in research and what
- 21:55things are being produced and generated,
- 21:59I started seeing different avenues or
- 22:02companies establishing or creating new assays
- 22:07that are blood based, not so invasive. Basically, when
- 22:10it's a blood test that can test for a large group
- 22:14of different types of cancers. And that made me think that,
- 22:18okay, if this technology is available and
- 22:21it's a blood test, it's not a colonoscopy, it's not a mammogram, it's not an
- 22:25X ray where you're exposed to radiation, why can't we
- 22:29start using that? It's not going to burden the healthcare system. Right.
- 22:33It's because it's a blood test. It's not an appointment
- 22:37for a CAT scan, it's not an appointment for a colonoscopy
- 22:41which will take away from other people who need it, it's just
- 22:44a regular blood test. You can go to any lab and do it. Why can't
- 22:47we start doing that for all the younger people who are not
- 22:51eligible to be screened with a colonoscopy or mammogram, for
- 22:55example, they don't have the high risk family history
- 22:58and see if we can start catching things early. And
- 23:02when I met the other co founders, they
- 23:06had similar thoughts before. They didn't have, for example, the experience that
- 23:10I had with seeing young patients, but they are seeing the trends. They
- 23:13have seen that cancer is on the rise. And of course
- 23:17both of them have or know someone with cancer. So
- 23:21there's Always that experience that touches everyone. And so
- 23:25when we met and we discussed this, we said,
- 23:28why don't we create a platform where people who don't have
- 23:32cancer but want to be screened have the chance to
- 23:35actually talk to oncologists, talk about the risk, and then actually
- 23:39have those assays that are being now
- 23:43developed and showing that they can detect cancer early be
- 23:46available for them. So that's how it started. I love that. That's a great
- 23:50story. What a. What a great. What a great venture. I mean, we need this
- 23:53so badly. Yeah. Like you, I've seen so many. So many young
- 23:57patients with just these sad stories of, you know, advanced cancer in their 20s and
- 24:0030s, and, you know, certainly in integrative
- 24:04oncology and in my field, you know, we talk a lot about nutrition and
- 24:07environmental exposures and all these things that we're still learning more about.
- 24:11But, I mean, something changed, right? We're not just catching cancer better.
- 24:15That's not why we're seeing more and more of it. We're not seeing it earlier.
- 24:17We're seeing something has changed. And if we can start catching
- 24:21it earlier, you know, we're going to improve outcomes. Right. Because as we talk
- 24:25about, you know, an ounce of prevention is worth a pound of cure. I mean,
- 24:28we. We. We catch a stage one or two. That's a very different conversation
- 24:32than a stage four. Yep. For sure. Exactly. I mean,
- 24:36there's no question there that catching cancer early at
- 24:39stage one will save lives. And, you know, it's very well
- 24:43documented that, you know, if you catch something at stage
- 24:46four, it's. In most cancers, it's incurable. If not.
- 24:50I mean, I don't want to say all cancers, because there are certain cases
- 24:53where it's still possible, but stage four is usually
- 24:57incurable at that point. And if we can catch it even at
- 25:00stage three is better than stage four, and there's a much higher rate of
- 25:04cure and basically surviving. And I don't want to say
- 25:08that the cancer field is not improving. It's actually very
- 25:11impressive what we're able to do these days, even for stage four cancers.
- 25:15And survival has definitely doubled and tripled and
- 25:19quadrupled in some cancers for stage four, because
- 25:22treatments have gotten better. But at the same time, for stage
- 25:26four, you actually, even with all the improvements, it's still not
- 25:30curable. And at the same time, you're still being exposed to treatments
- 25:34chronically all the time. You have to be on something, whether it's
- 25:37maintenance or several cycles of chemo before you can take a
- 25:41break. So there's always something that's going to keep affecting you, whether
- 25:45it starts causing side effects, it starts affecting your quality of life,
- 25:49it starts making you have to go to doctor's appointments every week,
- 25:53that that impacts people a lot. And so
- 25:56even though outcomes have gotten way better for stage four and you
- 26:00can do so much better if we can prevent all of
- 26:04that and just catch things so early, get rid of it at stage one, let's
- 26:07say you would avoid having to go
- 26:11through all of those therapies and toxicities that
- 26:15can really impact how you live. Right. Well said.
- 26:19So I'd like to dig a little deeper in terms of Palm Health. Which
- 26:22test specifically does Palm Health utilize to create a
- 26:26more robust cancer screening protocol? Yeah, so I
- 26:30mentioned earlier that there were several avenues or several companies
- 26:34out there that actually have built different assays that
- 26:38are blood based, that look for cancer, cancer signals
- 26:41basically. And so we looked at different ones and looked at
- 26:45their data and how long they've been there and
- 26:48if their long term follow up is actually impressive enough. And basically we
- 26:52compare them and the clear winner was a company gallery
- 26:56or Grail and their test was called, is called gallery.
- 27:00And you know, they've had multiple trials right now that look
- 27:03into screening and if that's actually catching things early
- 27:07and of course we need, I would say really
- 27:11decades to prove overall survival benefit from the time you actually
- 27:14screen and catch things. But at least it's a start that it's actually catching
- 27:18things early. And so there are even other companies that
- 27:22are now coming out with their own assays.
- 27:26And I would say right now we are
- 27:30very convinced with the assay that Gallery or Grail
- 27:33provides. And I tell this to everyone, we're not
- 27:37like focused on just one assay. We're always monitoring
- 27:41the changes in the field. And if in five years or
- 27:4510 years there's a very new powerful assay that catches even more
- 27:48things or has a higher sensitivity, we're definitely going to
- 27:52pivot. We will always go for the best assay to catch things.
- 27:56But of course the gallery assay is not the only one
- 28:00we utilize. There are other tests, blood based tests that we
- 28:04actually use as well, which normally they're used
- 28:08for monitoring for example, other cancers. So for
- 28:11example, there's CEA, there is AFP, there
- 28:15is CA15, 3 and CA125.
- 28:19So these are, for example, markers for different cancers like pancreatic,
- 28:22liver, breast, that we don't normally use them as screenings, but
- 28:26they definitely increase in the bloodstream when you
- 28:30have any of those cancers. And so in addition to
- 28:33the gallery test, we have those as part of the tests. Because,
- 28:37you know, the best way to really catch something is to try as
- 28:41much as possible to cover all the bases. Because like we
- 28:44mentioned before, there's always the possibility of a false positive or a false negative.
- 28:49And really to prove that this is a true
- 28:52signal, if you have two things that are positive, so one
- 28:56from the traditional assays in the blood and
- 28:59one signal coming from the gallery test that
- 29:03increases the likelihood that this is a true positive. And we actually
- 29:07really need to look deeper into that. So these are the main things
- 29:10that drive our screening platform. And so in addition
- 29:14to that, we do have a few other tests, one, a few that
- 29:18are urine based. For example, the best way to catch
- 29:21bladder cancer, for example, is to look for malignant, early
- 29:25malignant cells in the urine. Because once the bladder cancer starts
- 29:29forming, even at the very early stages, you can start shedding
- 29:33these tumor cells into the urine. And if you see them, then
- 29:36that should tell you or alarm you that there's something growing in the
- 29:40bladder. And people unfortunately don't catch bladder cancer until
- 29:44much later, because at later stages you start seeing
- 29:48blood in the urine, for example. But when it's so early, the urine will
- 29:52still look fine, but you can still see these cells, maybe it could be one
- 29:55cell even, but you'll still catch it and then you'll know there's something wrong.
- 29:59And then finally there is an imaging component which
- 30:03can really fill the whole picture and complete the whole
- 30:07picture. And out of all the imaging modalities,
- 30:11I definitely wanted something that is not super invasive.
- 30:15And what that means is lowering risk of any long
- 30:19term side effects. And that's why we went for
- 30:22magnetic based images rather than X rays.
- 30:27Exactly. So we went for whole body MRIs, because, you
- 30:31know, with CAT scans, for example, you still
- 30:34are exposed to radiation. It's not a dangerous level of
- 30:38radiation. But if we're talking about screening throughout your
- 30:41life, from a young age all the way until you're, let's say, 80,
- 30:46if you're always exposed to radiation, and if we end up doing this every
- 30:50year or every few years, you're going to be exposed to so much radiation
- 30:53over time, and that defeats the purpose. While being
- 30:57in a magnetic field, it's not really dangerous. And so
- 31:01that's why we also partnered with Prenova, which is one of the
- 31:05companies that actually also even uses AI in addition
- 31:08to radiologists to actually look at images to be
- 31:12as accurate and sensitive in catching things as possible. And
- 31:16that definitely will complete the picture, because not all
- 31:20cancers secrete things in the blood. And so
- 31:24if we're doing a blood test, we can catch a lot of things,
- 31:28but there's still a very, very small risk or
- 31:31possibility that whatever you have might not be secreting
- 31:35anything. There are cancers that don't secrete anything to begin with, and there are
- 31:38cancers even like breast cancer, where. Or
- 31:42pancreatic or colon, that can secrete their typical marker, but
- 31:46there would be a few cases where they don't at all. And then if we're
- 31:49purely relying just on the blood, then we'll miss it. And that's
- 31:53where the MRI or the full body MRI comes into
- 31:57play to help fill that gap. This is great. I mean, this is really like
- 32:00the Rolls Royce of. Of cancer screening. I mean, like you said, you kind of
- 32:03start with your base of gallery. And. And our listeners are familiar with that because
- 32:07at episode 86, we talked about the gallery test on here, and I use that
- 32:10with. I use that with my patients. Actually, after we've. We finished
- 32:14treatment, you know, six, eight, 12 months down the line, everything's looking
- 32:18good. Sometimes I'll do a gallery just to see if it picks up anything from
- 32:21what we've been treating as well as the 50 plus other types.
- 32:25But as you said, you know, that's. That's just a start because sometimes we need
- 32:29pictures too. And so the. Yeah, the full body mri. And that's a non
- 32:32contrast mri, correct? Yes, exactly. Yeah. Okay. And
- 32:36then that plus all the other testing. This is. This is awesome. So I.
- 32:40My understanding is with Palm Health, you have a few tiers, right? I think it's
- 32:43three tiers. So can you talk to us about the kind of. The tiers of
- 32:46testing that patients can kind of choose from? Mm, yeah. So we
- 32:50have three tiers, and the first two are
- 32:53purely blood, urine, and there's a stool study as
- 32:57well. And then the third tier is the one that includes
- 33:00imaging, which is prnovo. The reason we created three tiers is because,
- 33:05unfortunately, because all of these are still. Or at least
- 33:08the gallery test is still not FDA approved
- 33:12and covered by insurance, people will still
- 33:16have to. Exactly. Everything's still out of pocket. And especially if you're
- 33:20young and you don't have risk factors, you can't still. Right now,
- 33:23at least these days, you can't make the case for your insurance company
- 33:27to cover that for you. So we wanted at least
- 33:31to get some people to be able to be screened for at least a
- 33:35big chunk of the cancers that we can do with different
- 33:39tiers of out of pocket expenses. So there's the basic
- 33:42plan and then that is blood based. And
- 33:46it basically goes for at least 60, actually
- 33:5070 cancers just by looking into the blood. And
- 33:54it covers definitely all the basic ones and
- 33:57the more common ones. So including pancreatic cancer and
- 34:01colon cancer, liver cancer, rather than going into the more rarer
- 34:05ones like sarcomas for example, where it's
- 34:08definitely, it can definitely happen and exists, but it is
- 34:12less likely to be detected or to exist in,
- 34:16in fully healthy people. And then the second tier
- 34:19adds more blood tests or assays into this. The
- 34:23gallery test is part of all of them. So for sure you have
- 34:27that in all tiers. But then you add on top of it all those extra
- 34:30traditional tests that I mentioned that would really
- 34:34reconfirm any of the signals that we might or might not see
- 34:38with the gallery test. And so it basically is
- 34:41more blood tests to capture more cancers. And on our website
- 34:45actually we have a list of which cancers are covered
- 34:48under each tier. So we start with the basic one and then
- 34:52the next one is everything that the basic covers plus a
- 34:56list of cancers that we can, we will be able to detect with these extra
- 35:00tests that we added on. And then finally, like I mentioned, the
- 35:04third one would be just adding the imaging component which can help
- 35:07in detecting cancers that are either non secretory
- 35:11so they don't secrete anything to begin with and those are usually rare
- 35:15cancers or at the same time catch things that
- 35:18usually secrete things like colon cancer. But still you
- 35:22are one of the very, very few people whose colon cancer turned
- 35:26out not to secrete anything which can happen rare, but
- 35:30also exists. So the price range actually goes from
- 35:34around 1600 for the basic one, it
- 35:39doubles to around 3400 for the
- 35:43second one. And then when you add the imaging component that goes
- 35:46up to around 5,800. MRIs are still very
- 35:50expensive. But the one thing that we
- 35:54looked into as well is that seems like you
- 35:58are able to pay for all this through HSA
- 36:01accounts. So at least that is good start, that at
- 36:05least you can have those pre tax savings and use that
- 36:09money towards paying these. But we're hoping at some point in the future, over
- 36:12time and it wouldn't be just us. I think there's an interest in a lot
- 36:16of even academic centers to prove that screening for all those cancers actually
- 36:20improves outcomes, that at some point in the future all of this will be
- 36:23covered once we have enough data and long term outcomes that prove
- 36:27that using these modalities are catching more and more
- 36:31cancers. In younger people or people who are not at risk,
- 36:35and that is leading to cures and of course, survival,
- 36:38better survival. Right. So either there's something there and we're catching it
- 36:42sooner and we're improving, you know, odds of having a good outcome,
- 36:46or there's nothing there and you get tremendous peace of
- 36:49mind that you're, you're doing everything you can to, to sort of
- 36:53check for cancer and nothing was found. So that, that's to
- 36:57win either way, right? Yeah, exactly. Well, this is
- 37:01great. And then, and then. So if a, if a patient wants to
- 37:04pursue testing with Palm Health, is that something they need a referral from a doctor
- 37:08for, can they go on themselves to and sort of self refer.
- 37:11No, no, you, you don't need a referral. It's a self
- 37:15referral. You don't have to convince your primary care doctor to order it for
- 37:19you. That's great. No, no, we actually have a website,
- 37:23it's called palmhealth xyz. And so
- 37:27you just go to that website, you actually can go there and
- 37:30read more about us and about our approach, about all the tests
- 37:34that we utilize and what we look for, of course, the different
- 37:37plans that are available. And then if you are
- 37:41interested, there's also a wait list if you're still unsure if you. And if
- 37:45you are in states that are not covered yet because, you
- 37:48know, we're slowly covering more and more states because as you know, to
- 37:52be active medically in a state, you need a license. So we're
- 37:56slowly growing that. But we're definitely right now in the major states.
- 38:00In New England we have Massachusetts right now, but we also
- 38:04have New York. We're hoping to go soon into New
- 38:07Jersey. We have Florida, we have Texas, we have California. And
- 38:11of course we're now focusing on the Midwest as well. So we're
- 38:15slowly growing into different states so that more and more people
- 38:19can join. And unfortunately, because a lot of the people who
- 38:23are interested and reached out to us are in the states that we haven't
- 38:26covered yet. So what some of them have done so far
- 38:30is like they either have friends or family in the states that we
- 38:34have covered. So what they end up doing is they go visit those friends
- 38:38or they stay with the family and, and we have that telehealth
- 38:42visit from that state. So it's about where you are located
- 38:46rather than where you live. So as long as you travel and
- 38:50talk to us by telehealth from that state that we have
- 38:54covered, we should be fine. But we're hoping to expand
- 38:57more so that people don't really have to do that to talk to us. But
- 39:01we're in the process. We're still growing in the
- 39:05growing phase, so hopefully we'll get there soon. And so on that website,
- 39:08there's a couple of buttons that you can follow. One is for
- 39:13start screening, which basically goes through the different
- 39:16options that you can go. And then you can create an account,
- 39:20you can look at different plans and different options.
- 39:24You can actually ask questions first or like
- 39:27request callback or send an email and see
- 39:31if you need clarifications on a few things before you commit to anything.
- 39:35And then if you make a choice about how you want to be
- 39:39screened or you want to talk to someone first before you make a
- 39:42choice, that's also possible. And they then
- 39:46walk you through a list of questions to tell you or
- 39:50basically to know a little bit about your past medical history. And then
- 39:54after you finish that questionnaire, it then takes you to a
- 39:57calendar to pick a date and time that works for you to meet with the
- 40:01oncologist. And then once that day comes, you hop on
- 40:04a call, a telehealth visit basically with the oncologist. We go through
- 40:08your past medical history, you ask all the questions you want, we tell
- 40:12you about what the plan is, what we're planning to do. And then
- 40:16the process is after the call, the oncologist actually
- 40:19sends a script to a quest lab. So
- 40:23we partnered with Quest Diagnostics, which are all over the
- 40:27country. So we send a script for the labs that we want to use
- 40:31to screen to quest, and then the individual
- 40:34just has to go to their nearest quest lab. It doesn't have to
- 40:38be a specific quest lab. Any lab would have that
- 40:41script. And so they go there, the lab knows what
- 40:45to draw, and then they send it off. And so once the results come back,
- 40:49they come back to us and we post them on the portal. So you'll have
- 40:53all the results on the portal that you'll have access to if you
- 40:56create an account. And the oncologist will reach out to you again
- 41:00when everything is back, and they will tell you, okay, the
- 41:04results are back. When do you have some time to talk about them and
- 41:08go through them? And then we talk. If everything looks great, there's nothing
- 41:11else to do, if there's something concerning, then we talk about next steps,
- 41:15which could be if it's a very clear cut, like
- 41:19diagnosis that pops up, we know where to go. Like we know, let's
- 41:22say gastric cancer is what we find. So we make the
- 41:26appropriate connection to make sure you go to an oncologist,
- 41:30either a specialist in gastric cancer or a general oncologist, at least take the
- 41:34next steps or plan for biopsies if there is a mass
- 41:37somewhere, for example, that pops up on imaging and we need to investigate that.
- 41:41But then these things would be done locally. Right?
- 41:45It wouldn't like doing a biopsy. We cannot do that ourselves
- 41:49since this is a telehealth platform. So we would connect you with someone
- 41:53who you can go to in person and do the next steps
- 41:56for diagnosis. That's great. I applaud you for doing this.
- 42:00This is. This is so needed. And to be able to sort of package all
- 42:04this into one testing program is great because I'm just thinking if
- 42:08someone tried to do all this individually, how many doctor visits would it take to
- 42:11get referrals for each of these tests and orders and try to organize
- 42:15it all and then. And then someone to make sense of all of it. This
- 42:18is great that you package all of it together in a. In one comprehensive
- 42:22testing package. Yeah. Thank you. I mean,
- 42:26that made the most sense. We. I know going through
- 42:30this is definitely a hard journey to get all of these things
- 42:33together. So packaging or packaging it all in one platform
- 42:37and having done colleges also being part of it is.
- 42:41It's definitely a lot of effort to put all of this together, but I think
- 42:44that would provide the best experience and the smoothest experience to people
- 42:47who want to be screened for cancer. And you said the website again was
- 42:51Palm Health dot xyz? Yep, that's correct. That's
- 42:55P O M Health xyz. Okay, great. I know our listeners will
- 42:59be excited to check that out. Well, Dr. Mouhieddine, anything else
- 43:02you wanted to cover with us? Anything we didn't touch on that we. You wanted
- 43:06to leave our listeners with? No, I think we. We touched on
- 43:10everything we wanted to actually bring up. And you
- 43:13know, my interest here and my passion about this is
- 43:17really that I want people to know that
- 43:21unfortunately cancer risk and cancer incidence is rising.
- 43:25And we think, while we don't have all explanations to it yet, I
- 43:28think, I personally believe it, eventually we'll see that it has to do
- 43:32with environmental exposures as our world is changing. And
- 43:36until then, I think what we can do right now is being
- 43:40proactive about detecting things early because we know the
- 43:43risk is now higher and because we have the technologies
- 43:47now, I think that are not so invasive anymore.
- 43:51I think being proactive about things will make a big difference on the
- 43:55long run. I've seen unfortunately firsthand young people
- 43:58going through Stage four cancer, which if they were
- 44:02caught early, we would have. They would be still living their life fully,
- 44:06unfortunately. And for now, the thing that we can
- 44:10do is this. I'm hoping that this effort will
- 44:14keep growing in the future and not just with us, but from other avenues
- 44:17as well. And as we show in the future that this is
- 44:21helping people and saving lives, I think it'll become more and more
- 44:25accessible. It'll be covered. I really hope so. Because
- 44:29what. Even though this is great and makes me happy that
- 44:32we are doing this effort and actually screening and making sure people
- 44:36are in good shape, it still frustrates me and makes me sad
- 44:40that it's also not so accessible. If I wish this, we
- 44:44could get this done fully covered for everyone by
- 44:47insurance or by Medicare or Medicaid, but
- 44:51we're not there yet. But I'm hoping that at some point in the future that
- 44:54will be the case so that everybody gets equitable access to all of
- 44:58this. Really good. And I believe
- 45:02eventually life saving technology. Yeah, I believe we'll get
- 45:05there too. And you know, because everyone, everyone deserves
- 45:09to have. This is, is honestly part of their standard of care in terms of
- 45:13just preventive maintenance and wellness visits. Right. I mean, this should be part
- 45:16of it. Yeah. Just as we screen for heart disease and diabetes,
- 45:20we should be screening for cancer to this level as well. So. Yeah,
- 45:24yeah, I completely agree. And while not everyone is still on,
- 45:28on that same page, I think more and more doctors are beginning to
- 45:32really see the benefit and the advantage of having this.
- 45:36And I think it's a matter of time before we have more and more proof
- 45:40even that this is how things should be done and this is how
- 45:44the world is going to change into. It's about more being proactive
- 45:48and screening early so that we avoid the
- 45:51long term side effects and the long term consequences,
- 45:56if you can call it consequences, but like avoiding
- 45:59basically stage four. Living in a world where stage one
- 46:03is the late or the most advanced cancer that we get to.
- 46:07I love that goal. Let's do it. Let's do it. Yeah. Well, Dr.
- 46:11Mouhieddine, thank you again for your time today. I know you're a busy guy and
- 46:14you've got a lot going on and really, really honored that you chose to spend
- 46:17some time with us today. No, it was, it was a pleasure and an honor
- 46:20for me as well. Thank you so much for having me on your program and
- 46:24I look forward to connecting with you again in the future. And
- 46:29for all your listeners, you know, like I mentioned, if they want to
- 46:33know more, they can go to the website and of course they can request a
- 46:36call as well if they needed more clarifications about things. So
- 46:40some of, some of the people who have created accounts
- 46:44and we've met through Palm Health, actually sometimes they before
- 46:48they made that commitment they actually started with a clarification call like they
- 46:51wanted to better understand a few things. So I highly encourage people to do that
- 46:55as well if they're not 100% sure about what to do.
- 46:58Okay, sounds great. Well, thank you again. And again that's palmhealth xyz. I
- 47:02encourage our listeners to check that out. We're interested in really doing the,
- 47:06the, the finest screening that we have available today. So
- 47:10but thank you again. And just a reminder to our listeners, you know, we have
- 47:14many, many more great episodes coming your way in this season, in future
- 47:17seasons. But thank you again for joining us. And until next time,
- 47:21bye bye. Goodbye.